Skip to main content

Table 1 Patient suspected diagnosis, demographics, and baseline characteristics

From: Diagnostic testing managed by hematopathology specialty and other laboratories: costs and patient diagnostic outcomes

 

Total

Genoptix

Large Labs

Other Controls

p-value

Study population size

(N = 24,664)

(N = 1,387)

(N = 4,162)

(N = 19,115)

 
 

n

%

n

%

n

%

n

%

 

Suspected diagnoses

MDS

859

3.48

23

1.66

128

3.08

708

3.70

<0.001

MPN

1,004

4.07

61

4.40

159

3.82

784

4.10

0.578

CLL

816

3.31

38

2.74

126

3.03

652

3.41

0.217

MM

1,507

6.11

68

4.90

198

4.76

1,241

6.49

<0.001

NHL

4,894

19.84

215

15.50

814

19.56

3,865

20.22

<0.001

Other hematologic cancer

2,787

11.30

53

3.82

253

6.08

2,481

12.98

<0.001

Other hematologic conditions

13,815

56.01

932

67.20

2,537

60.96

10,346

54.13

<0.001

Gender

Male

12,979

52.62

687

49.53

2,199

52.84

10,093

52.80

0.060

 

Female

11,685

47.38

700

50.47

1,963

47.16

9,022

47.20

0.060

Age group

0-17

872

3.54

0

0.00

20

0.48

852

4.46

<0.001

18-44

3,813

15.46

226

16.29

681

16.36

2,906

15.20

0.117

45-64

10,272

41.65

636

45.85

1,911

45.92

7,725

40.41

<0.001

65+

9,707

39.36

525

37.85

1,550

37.24

7,632

39.93

0.003

Insurance type

Commercial

18,639

75.57

1,068

77.00

3,280

78.81

14,291

74.76

<0.001

 

Medicare

6,025

24.43

319

23.00

882

21.19

4,824

25.24

<0.001

Baseline therapy

Pre-index chemotherapy

1,908

7.74

83

5.98

291

6.99

1,534

8.03

0.003

Pre-index radiation therapy

1,556

6.31

70

5.05

240

5.77

1,246

6.52

0.027

History of radiation therapy

71

0.29

2

0.14

8

0.19

61

0.32

0.226

Geographical distribution

Northeast

2,391

9.69

62

4.47

512

12.30

1,817

9.51

<0.001

Midwest

6,945

28.16

104

7.50

667

16.03

6,174

32.30

<0.001

South

11,882

48.18

1,027

74.04

2,660

63.91

8,195

42.87

<0.001

West and other

3,442

13.96

193

13.91

322

7.74

2,927

15.31

<0.001

Unknown

4

0.02

1

0.07

1

0.02

2

0.01

0.200

Presence of down’s syndrome

31

0.13

1

0.07

1

0.02

29

0.15

0.092

Age (in years)

Mean (SD)

58.49

(18.04)

59.88

(15.12)

59.39

(15.46)

58.19

(18.73)

<0.001

Median

60.00

 

60.00

 

60.00

 

60.00

  

Pre-index Quan-Charlson comorbidity score

Mean (SD)

2.18

(2.11)

2.08

(2.11)

2.04

(2.01)

2.22

(2.13)

<0.001

Median

2.00

 

2.00

 

2.00

 

2.00

  

Distance to MSA

Mean (SD)

3.09

(11.73)

2.96

(10.26)

2.25

(10.26)

3.28

(12.11)

<0.001

 

Median

0.00

 

0.00

 

0.00

 

0.00

  
  1. Abbreviations: MDS Myelodysplastic syndrome, MPN Myeloproliferative neoplasms, CLL Chronic lymphoid leukemia, MM Multiple myeloma, NHL Non-Hodgkin’s lymphoma, MSA Metropolitan statistical area, SD Standard deviation.
Back to article page

BMC Clinical Pathology

ISSN: 1472-6890

Contact us